Rosacea;Rosácea

Actas Dermo-Sifiliograficas

Volumn 99, Issue 4, 2008, Pages 244-256

  Barco, D ^a   Alomar Muntañola , Agustín ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Azelaic acid; Demodex folliculorum; Flushing; Metronidazole; Retinoids; Rosacea; Tetracyclines

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AZELAIC ACID; AZITHROMYCIN; BENZOYL PEROXIDE; CLARITHROMYCIN; CLINDAMYCIN; CLONIDINE; DISULFIRAM; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; METRONIDAZOLE; MINOCYCLINE; NALOXONE; ONDANSETRON; ORAL CONTRACEPTIVE AGENT; PIMECROLIMUS; PLACEBO; POTASSIUM IODIDE; PROPYLENE GLYCOL; RETINOIC ACID; SEROTONIN UPTAKE INHIBITOR; SULFACETAMIDE; SULFUR; TACROLIMUS; TETRACYCLINE; TITANIUM DIOXIDE; UNINDEXED DRUG; ZINC OXIDE;

CLINICAL FEATURE; CLINICAL TRIAL; CRYOSURGERY; DEMODEX; DEMODEX FOLLICULORUM; DIFFERENTIAL DIAGNOSIS; ELECTROSURGERY; ERYTHEMA; FLUSHING; HUMAN; INFECTION; PAPULE; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PREVALENCE; PUSTULE; REVIEW; RISK FACTOR; ROSACEA; SKIN CARE; SYMPTOM; TELANGIECTASIA; VASCULAR DISEASE;

EID: 44349135196     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(08)74672-6     Document Type: Review

References (81)

1. J.Q. Del Rosso Update on rosacea pathogenesis and correlation with medical therapeutic agents Cutis 78 2006 97 100
2. K.J. Butterwick L.S. Butterwick A. Han Laser and light therapies for acne rosacea J Drugs Dermatol 5 2006 35 39
3. H.E. Baldwin Oral therapy for rosacea J Drugs Dermatol 5 2006 16 21
4. B. Berman D. Zell Subantimicrobial dose doxycycline: a unique treatment for rosacea Cutis 75 Suppl 4 2005 19 24
5. R.I. Ceilley Advances in the topical treatment of acne and rosacea J Drugs Dermatol 3 Suppl 5 2004 S12 22
6. R.H. Liu M.K. Smith S.A. Basta E.R. Farmer Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials Arch Dermatol 142 2006 1047 1052
7. S.A. Buechner Rosacea: an update Dermatology 210 2005 100 108
8. S. Diamantis H.A. Waldorf Rosacea: clinical presentation and pathophysiology J Drugs Dermatol 5 2006 8 12
9. S. Laube S.W. Lanigan Laser treatment of rosacea J Cosmet Dermatol 1 2002 188 195
10. A.K. Gupta M.M. Chaudhry Rosacea and its management: an overview J Eur Acad Dermatol Venereol 19 2005 273 285
11. G.H. Crawford M.T. Pelle W.D. James Rosacea: I. Etiology, pathogenesis, and subtype classification J Am Acad Dermatol 51 2004 327 341
12. E.J. van Zuuren A.K. Gupta M.D. Gover M. Graber S. Hollis Systematic review of rosacea treatments J Am Acad Dermatol 56 2007 107 115
13. R. Odom The nosology of rosacea Cutis 74 Suppl 3 2004 5 8 32-4
14. J. Wilkin M. Dahl M. Detmar L. Drake A. Feinstein R. Odom Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea J Am Acad Dermatol 46 2002 584 587
15. National Rosacea Society. New survey pinpoints leading factors that trigger symptoms [online]. Summer 2002. Rosacea Review. Disponible en: http://www.rosacea.org/rr/2002/summer/article_3.php
16. J.K. Wilkin Why is flushing limited to a mostly facial cutaneous distribution? J Am Acad Dermatol 19 1988 309 313
17. G. Murphy Ultraviolet light and rosacea Cutis 74 Suppl 3 2004 13 16 32-4
18. A.R. Amin M.G. Attur G.D. Thakker P.D. Patel P.R. Vyas R.N. Patel A novel mechanism of action of tetracyclines: effects on nitric oxide synthases Proc Natl Acad Sci U S A 93 1996 14014 14019
19. M. Berg S. Liden An epidemiological study of rosacea Acta Derm Venereol 69 1989 419 423
20. R. Marks Concepts in the pathogenesis of rosacea Br J Dermatol 80 1968 170 177
21. M. Lee J. Koo Rosacea, light, and phototherapy J Drugs Dermatol 4 2005 326 329
22. E. Nunzi A. Rebora F. Hamerlinck R.H. Cormane Immunopathological studies on rosacea Br J Dermatol 103 1980 543 551
23. T.J. Ryan The blood vessels of the skin J Invest Dermatol 67 1976 110 118
24. R. Marks J.N. Harcourt-Webster Histopathology of rosacea Arch Dermatol 100 1969 683 691
25. A.A. Ramelet G. Perroulaz Rosacea: histopathologic study of 75 cases Ann Dermatol Venereol 115 1988 801 806
26. S. Ayres S Jr S. Ayres 3rd Demodectic eruptions (demodicidosis) in the human. 30 years’ experience with 2 commonly unrecognized entities: pityriasis folliculorum (Demodex) and acne rosacea (Demodex type) Arch Dermatol 83 1961 816 827
27. E. Bonnar P. Eustace F.C. Powell The Demodex mite population in rosacea J Am Acad Dermatol 28 1993 443 448
28. J.L. Díaz-Pérez Demodex mites in rosacea J Am Acad Dermatol 305 Pt 1 1994 812 813
29. R. Marks Histogenesis of the inflammatory component of rosacea Proc R Soc Med 66 1973 742 745
30. S. Georgala A.C. Katoulis G.D. Kylafis E. Koumantaki-Mathioudaki C. Georgala K. Aroni Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea J Eur Acad Dermatol Venereol 15 2001 441 444
31. R. Hoekzema H.J. Hulsebosch J.D. Bos Demodicidosis or rosacea: what did we treat? Br J Dermatol 133 1995 294 299
32. B. Amichai M.H. Grunwald I. Avinoach S. Halevy Granulomatous rosacea associated with Demodex folliculorum Int J Dermatol 31 1992 718 719
33. F. Forton B. Seys Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy Br J Dermatol 128 1993 650 659
34. Z. Erbagcči O. Ozgöztaşi The significance of Demodex folliculorum density in rosacea Int J Dermatol 37 1998 421 425
35. A. Rebora Rosacea J Invest Dermatol 88 Suppl 3 1987 56 60
36. I.K. Aronson J.A. Rumsfield D.P. West J. Alexander J.H. Fischer F.P. Paloucek Evaluation of topical metronidazole gel in acne rosacea Drug Intell Clin Pharm 21 1987 346 351
37. N.J. Lowe T. Henderson L.E. Millikan S. Smith K. Turk F. Parker Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial Cutis 43 1989 283 286
38. A. Szlachcic The link between Helicobacter pylori infection and rosacea J Eur Acad Dermatol Venereol 16 2002 328 333
39. G. Argenziano G. Donnarumma M.R. Iovene P. Arnese M.A. Baldassarre A. Baroni Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients Int J Dermatol 42 2003 601 604
40. M.A. Gürer A. Erel D. Erbas¸ K. Cagčlar C. Atahan The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea Int J Dermatol 41 2002 768 770
41. A. Rebora F. Drago A. Picciotto Helicobacter pylori in patients with rosacea Am J Gastroenterol 89 1994 1603 1604
42. S. Utas O. Ozbakir A. Turasan C. Utas Helicobacter pylori eradication treatment reduces the severity of rosacea J Am Acad Dermatol 40 1999 433 435
43. J.T. Bamford Rosacea: current thoughts on origin Semin Cutan Med Surg 20 2001 199 206
44. V.K. Sharma A. Lynn M. Kaminski R. Vasudeva C.W. Howden A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea Am J Gastroenterol 93 1998 220 222
45. J.T. Bamford R.L. Tilden J.L. Blankush D.E. Gangeness Effect of treatment of Helicobacter pylori infection on rosacea Arch Dermatol 135 1999 659 663
46. A. Szlachcic Z. Sliwowski E. Karczewska W. Bielanski J. Pytko Polonczyk S.J. Konturek Helicobacter pylori and its eradication in rosacea J Physiol Pharmacol 50 1999 777 786
47. F.C. Powell Rosacea and the pilosebaceous follicle Cutis 74 Suppl 3 2004 9 12 32-4
48. D.M. Reifler D.D. Verdier C.L. Davy N.D. Mostow V.E. Wendt Multiple chalazia and rosacea in a patient treated with amiodarone Am J Ophthalmol 103 1987 594 595
49. H.L. Franco W.L. Weston Steroid rosacea in children Pediatrics 64 1979 36 38
50. E.F. Sherertz Acneiform eruption due to «megadose» vitamins B6 and B12 Cutis 48 1991 119 120
51. M.T. Pelle G.H. Crawford W.D. James Rosacea: II. Therapy J Am Acad Dermatol 51 2004 499 512
52. J.Q. Del Rosso Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants Cutis 75 Suppl 3 2005 17 21
53. T. Dirschka H. Tronnier R. Fölster-Holst Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis Br J Dermatol 150 2004 1136 1141
54. National Rosacea Society. Survey finds that rosacea flare-ups are common but can be controlled [online]. Spring 1999. Rosacea Review. Disponible en: http://www.rosacea.org/rr/1999/spring/article_3.php
55. Z.D. Draelos Cosmetics in acne and rosacea Semin Cutan Med Surg 20 2001 209 214
56. J.B. Bikowski The pharmacologic therapy of rosacea: a paradigm shift in progress Cutis 75 Suppl 3 2005 27 32
57. J.Q. Del Rosso J. Bikowski Topical metronidazole combination therapy in the clinical management of rosacea J Drugs Dermatol 4 2005 473 480
58. J.E. Wolf Jr Present and future rosacea therapy Cutis 75 Suppl 3 2005 4 7
59. S. Maddin A comparison of topical azelaic acid 20 % cream and topical metronidazole 0.75 % cream in the treatment of patients with papulopustular rosacea J Am Acad Dermatol 40 Pt 1 1999 961 965
60. B.W. Elewski Azelaic acid 15 % gel for treatment of rosacea Expert Rev Dermatol 1 2006 535 545
61. D. Thiboutot R. Thieroff-Ekerdt K. Graupe Efficacy and safety of azelaic acid (15 %) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies J Am Acad Dermatol 48 2003 836 845
62. A. Rebora The management of rosacea Am J Clin Dermatol 3 2002 489 496
63. D.N. Sauder R. Miller D. Gratton W. Danby C. Griffiths S.B. Phillips The treatment of rosacea: the safety and efficacy of sodium sulfactemide 10 % and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study J Dermatol Treat 8 1997 79 85
64. M. Lebwohl R.S. Medansky C.L. Russo R.T. Plott The comparative efficacy sodium sulfacetamide 10 % and sulfur 5% (Sulfacet-R) lotion and metronidazole 0.75 % (MetroGel) in the treatment of rosacea J Geriatr Dermatol 3 1995 183 185
65. O.H. Mills Jr A.M. Kligman Letter: Topically applied erythromycin in rosacea Arch Dermatol 112 1976 553 554
66. J.K. Wilkin S. DeWitt Treatment of rosacea: topical clindamycin versus oral tetracycline Int J Dermatol 32 1993 65 67
67. A.M. Kligman D. Dogadkina R.M. Lavker Effects of topical tretinoin on non-sun-exposed protected skin of the elderly J Am Acad Dermatol 29 1993 25 33
68. J.H. Saurat L. Didierjean E. Masgrau P.A. Piletta S. Jaconi D. Chatellard-Gruaz Topical retinaldehyde on human skin: biologic effects and tolerance J Invest Dermatol 103 1994 770 774
69. J.Q. Del Rosso A status report on the medical management of rosacea: focus on topical therapies Cutis 70 2002 271 275
70. D. Goldman Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report J Am Acad Dermatol 44 2001 995 998
71. G. Webster J.Q. Del Rosso Anti-inflammatory activity of tetracyclines Dermatol Clin 25 2007 133 135
72. M.V. Dahl Rosacea subtypes: a treatment algorithm Cutis 74 Suppl 3 2004 21 27 32-4
73. M.J. Quarterman D.W. Johnson D.C. Abele J.L. Lesher Jr D.S. Hull L.S. Davis Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline Arch Dermatol 133 1997 49 54
74. A. Fernández-Obregón Oral use of azithromycin for the treatment of acne rosacea Arch Dermatol 140 2004 489 490
75. C. Torresani Clarithromycin: a new perspective in rosacea treatment Int J Dermatol 37 1998 347 349
76. K. Turjanmaa T. Reunala Isotretinoin treatment of rosacea Acta Derm Venereol 67 1987 89 91
77. F.G. Erdogan P. Yurtsever D. Aksoy F. Eskioglu Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea Arch Dermatol 134 1998 884 885
78. J.K. Wilkin Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions Arch Dermatol 119 1983 211 214
79. J.K. Wilkin Effect of nadolol on flushing reactions in rosacea J Am Acad Dermatol 20 Pt 1 1989 202 205
80. J.E. Bernstein K. Soltani Alcohol-induced rosacea flushing blocked by naloxone Br J Dermatol 107 1982 59 61
81. H. Aizawa M. Niimura Oral spironolactone therapy in male patients with rosacea J Dermatol 19 1992 293 297